Oncology Information System Market Valued at USD 3.3 Bn in 2024, Set to Grow at 7.2% CAGR Through 2035

The global Oncology Information System (OIS) Market was valued at USD 3.3 Bn in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2035, reaching USD 7.1 Bn by the end of 2035. Market growth is driven by the increasing prevalence of cancer, rising demand for integrated oncology care solutions, and the growing adoption of digital healthcare technologies. Oncology information systems help healthcare providers manage patient data, treatment planning, clinical workflows, and radiation therapy processes more efficiently

👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18659

Market Overview

Global oncology information systems (OIS) market is growing at a rapid rate. As such, hospitals and cancer treatment centers are pushed to adopt electronic systems that can streamline processes, combine patient data, and support decision-making. Shifting toward precision oncology and personalized treatment also underlines the necessity of the same, as the systems enable the doctor to tailor the treatment as per the profile of the patient.

There were around 20 new cancer diagnoses and almost 10 cancer-related deaths in the year 2022 alone, thereby increasing the burden on the healthcare system even more to deliver timely and effective oncology care. One of the most powerful drivers to this market is the convergence of artificial intelligence and machine learning technologies. OIS platforms can provide intensive treatment regimens across all oncology domains.

They provide a unified platform to monitor the progress of the patient, coordinate care across several teams, and facilitate data-driven planning of the treatment. These technologies enable real-time patient monitoring, predictive analytics, and computerized treatment planning, thereby enhancing clinical outcomes and relief of administrative burden.

 Analysts' Viewpoint

The global oncology information system (OIS) market is growing strongly, fueled primarily by the rising global burden of cancer and the need for efficient data management in cancer treatment. Such systems streamline clinical workflows by integrating patient data, treatment planning, and progress tracking in radiology, medical, and surgical oncology departments. Increased focus on precision oncology and personalized medicine is also driving adoption.

Progress in AI-based analytics, cloud-based platforms, and interoperable architecture is changing the competitive landscape. Integration with electronic health records and imaging applications is becoming the norm. Companies are positioning themselves strategically through product development, multi-institutional collaborations, and geographic expansion to solidify positions.

 Analysis of Key Players

• Leading healthcare IT corporations are developing integrated OIS platforms that seamlessly bridge radiation, medical, and surgical oncology data streams.
• Companies are investing in artificial intelligence and machine learning modules to support predictive analytics, risk stratification, and personalized treatment-response modeling.
• Organizations are expanding cloud-based deployment portfolios to ensure secure, multi-site data access and reduced facility-level IT maintenance burdens.
• Industry participants are strengthening strategic partnerships with hospital networks, research institutions, and major electronic health record (EHR) vendors.
• Companies are focusing on standardized FHIR-compliant interfaces and pre-certified connectors to improve data exchange across laboratory and radiology information systems.

Recent Developments

• In August 2021, Siemens Healthineers acquired Varian Medical Systems to create a unique, integrated portfolio of oncology information system workflows.
• In June 2021, Koninklijke Philips N.V. announced that it had partnered with Elekta to develop advanced, personalized cancer care through precision oncology information solutions.

 👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18659

Key Developments & Trends

• Precision Oncology Integration: Growing adoption of genomic and molecular profiling is driving the need for OIS platforms capable of handling complex biomarker data.
• AI & Predictive Analytics: Escalating utilization of machine learning algorithms for treatment planning and toxicity prediction is transforming conventional software.
• Cloud-Based Deployment: Transition toward scalable cloud infrastructure is facilitating centralized data management across multi-site hospital networks.
• Multidisciplinary Coordination: Increasing need for seamless communication between medical, radiation, and surgical teams remains a core driver for integrated system adoption.

Challenges

• High Implementation Costs: Substantial upfront capital expenditures required for software licensing, custom integrations, and staff training can strain facility budgets.
• Interoperability Barriers: Achieving seamless data exchange between specialized OIS platforms and legacy hospital EHR systems remains technically complex.
• Data Security and Privacy: Managing sensitive patient genomic and medical data requires rigorous cybersecurity frameworks and strict regulatory compliance.
• Workflow Disruption: Transitioning clinical teams to new software environments can temporarily impact operational efficiency during the adoption phase.

Opportunities

• AI-Driven Clinical Decision Support: Developing advanced cognitive tools that assist oncologists with real-time treatment recommendations offers high-margin software expansion.
• Emerging Regional Markets: Rapid healthcare digitalization and rising cancer care investments across Asia-Pacific provide strong multi-year volume growth.
• SaaS and Cloud-Native Models: Offering subscription-based, scalable cloud solutions lowers financial entry barriers for smaller community oncology practices.
• Real-World Evidence (RWE) Analytics: Leveraging aggregated, anonymized OIS databases to support pharmaceutical clinical trials creates lucrative secondary revenue streams.

Market Segmentation

• Solution
• Software
• Patient Information Systems
• Electronic Medical Records
• Laboratory Information Systems
• Radiology Information Systems
• Others (Chemotherapy Information Systems, etc.)
• Treatment Planning Systems
• Clinical Decision Support Systems
• Brachytherapy Treatment Planning Systems
• Others (Radiotherapy Treatment Planning Systems, etc.)
• Others (Population Health Management Systems, PACS, VNA, etc.)
• Services
• Application
• Medical Oncology
• Radiation Oncology
• Surgical Oncology
• End-user
• Hospitals & Ambulatory Surgical Centers
• Diagnostic & Imaging Centers
• Ablation & Cancer Care Centers
• Others (Research Facilities, etc.)

 Conclusion

The global oncology information system market is projected to grow from USD 3.3 Bn in 2024 to USD 7.1 Bn by the end of 2035, advancing at a CAGR of 7.2% from 2025 to 2035. Rising cancer prevalence, escalating treatment complexity, and continuous technological advancements in AI and cloud computing are expected to remain key market growth drivers. Advances in interoperable architecture, precision medicine tracking, and multidisciplinary care coordination are likely to create new opportunities for industry participants.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=18659<ype=S

Frequently Asked Questions

·        How big was the oncology information system (OIS) market in 2024?

The oncology information system (OIS) market was valued at US$ 3.3 Bn in 2024.

·        How big will the oncology information system (OIS) business be in 2035?

The oncology information system (OIS) market is projected to cross US$ 7.1 Bn by the end of 2035.

·        What are the factors driving the oncology information system (OIS) market?

Rising global cancer burden and shift toward precision oncology and AI-driven treatment.

·        What will be the CAGR of the oncology information system (OIS) industry during the forecast period?

The CAGR is anticipated to be 7.2% from 2025 to 2035.

·        Which region will account for a major share of the oncology information system (OIS) sector during the forecast period?

North America is expected to account for the largest share from 2025 to 2035.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com  

Sales Inquiries: sales@transparencymarketresearch.com  

Media Inquiries: media@transparencymarketresearch.com